Literature DB >> 2619420

Effects of pantethine, cysteamine and pantothenic acid on open-field behavior and brain catecholamines in rats.

L Vécsei1, E Widerlöv, C Alling.   

Abstract

Cysteamine (1.95 mM/kg) markedly decreased the locomotor, rearing and grooming activities, as well as the number of defecation boluses in an open-field test. An equimolar dose of pantethine reduced the locomotor activity to a lesser extent, but has the same potency in decreasing the number of defecation boluses, whereas pantothenic acid did not affect the behavior of the rats. Cysteamine, and to a lesser extent pantethine, reduced the noradrenaline and increased the dopamine and DOPAC concentrations in the hypothalamus. Pantothenic acid itself did not influence the hypothalamic catecholamine concentrations. These results suggest that the lower efficacy of pantethine compared to cysteamine on both behavioral and neurochemical parameters is probably due to a rate-limiting activity of the enzyme pantetheinase in the conversion of pantetheine to cysteamine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2619420

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  2 in total

1.  Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer's Disease Pathogenesis in a Transgenic Mouse Model.

Authors:  Kevin Baranger; Manuel van Gijsel-Bonnello; Delphine Stephan; Wassila Carpentier; Santiago Rivera; Michel Khrestchatisky; Bouchra Gharib; Max De Reggi; Philippe Benech
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

Review 2.  Natural Molecules and Neuroprotection: Kynurenic Acid, Pantethine and α-Lipoic Acid.

Authors:  Fanni Tóth; Edina Katalin Cseh; László Vécsei
Journal:  Int J Mol Sci       Date:  2021-01-02       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.